Gregory W. Smith

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results

Aptamers as targeted therapeutics: current potential and challenges

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Therapeutic RNA aptamers in clinical trials

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

Mitomycin C in combination with capecitabine or biweeklyhigh-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Aptamers as radiopharmaceuticals for nuclear imaging and therapy

Band Bending in Semiconductors: Chemical and Physical Consequences at Surfaces and Interfaces

Electronic structure and electron dynamics at Si(100)

New perspectives on context-based chemistry education: using a dialectical sociocultural approach to view teaching and learning

DNA origami protection and molecular interfacing through engineered sequence-defined peptoids

Anisotropic thermal displacements of adsorbed atoms and molecules on surfaces studied by low-energy electron diffraction

Aprendizaje de las ciencias basado en proyectos: del contexto a la acción

Programmable and Multifunctional DNA‐Based Materials for Biomedical Applications

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Science, technology and society in transition year: A pilot study

Subpicosecond interconversion of buckled and symmetric dimers on Si(100)

Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma

A phase II, single-arm study of AS1411 in metastatic renal cell carcinoma (RCC).